Washington Wrap-Up
Jan 17, 2012
In both the case of the user fees and dental amalgam, FDA did it again: It missed a promised deadline and, in doing so, demonstrated why its officials...
Jan 17, 2012
A review of clinical trials, observational studies, and registries produced limited evidence on comparative effectiveness of various hip implant bearing...
Jan 17, 2012
  To those who feel the increased presence of FDA investigators responding to commissioner Margaret Hamburg’s purported new emphasis on enforcement...
Dec 19, 2011
A CDRH report says greater visibility on the agency’s expectations of device quality and properly aligning its regulatory approach are needed to...
Dec 19, 2011
The Consumers Union (CU) is getting involved in the debate over the medical device approval process, asking Congress to bolster FDA’s standards for...
Dec 19, 2011
Sweeping new legislation drafted by Senator Kay Hagan (D-NC) in collaboration with the Biotechnology Industry Organization would establish a powerful...
Dec 19, 2011
As if to preempt external examination of its internal workings, CDRH included in a report on its premarket review programs a promise that it is going to...
Dec 19, 2011
The institutional culture at FDA has been gingerly discussed (if at all) for decades. As a major election year gets underway, the agency and its...
Dec 17, 2011
It’s time to revive the idea of third-party medical device reviews because CDRH “simply cannot acquire or maintain the levels of necessary...
Dec 13, 2011
An FDA proposal to apply user fee revenues to retention bonuses for its medical device employees got short shrift from industry negotiators at an August 31...